NEW YORK (GenomeWeb) – Cancer Genetics today said that it has received $1.1 million in net cash proceeds from the transfer of tax credits approved by the New Jersey Economic Development Authority's Technology Business Tax Certificate Transfer program.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.